Stay updated with breaking news from Immunic Daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com cut shares of Immunic (NASDAQ:IMUX – Free Report) from a hold rating to a sell rating in a research note published on Saturday morning. Separately, Brookline Capital Management reaffirmed a buy rating and set a $10.00 target price on shares of Immunic in a research report on Friday, April 5th. View Our Latest Report […]
Investment analysts at Brookline Capital Management began coverage on shares of Immunic (NASDAQ:IMUX – Get Free Report) in a research report issued to clients and investors on Friday, Benzinga reports. The firm set a “buy” rating and a $10.00 price target on the stock. Separately, StockNews.com downgraded shares of Immunic from a “hold” rating to […]
Sweet Financial Partners LLC purchased a new stake in Immunic, Inc. (NASDAQ:IMUX – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 29,829 shares of the company’s stock, valued at approximately $45,000. Sweet Financial Partners LLC owned 0.07% of Immunic at the […]
Immunic (NASDAQ:IMUX – Get Free Report) will be announcing its earnings results before the market opens on Thursday, February 22nd. Analysts expect the company to announce earnings of ($0.51) per share for the quarter. Immunic (NASDAQ:IMUX – Get Free Report) last released its earnings results on Tuesday, November 14th. The company reported ($0.51) EPS for […]
Immunic, Inc. (NASDAQ:IMUX – Free Report) – Analysts at Leerink Partnrs issued their FY2028 earnings per share estimates for shares of Immunic in a research report issued to clients and investors on Monday, February 5th. Leerink Partnrs analyst T. Smith expects that the company will earn ($0.66) per share for the year. The consensus estimate […]